Agents for treatment of diabetic retinopathy and drusen formation in macular degeneration

Details for Australian Patent Application No. 2004308911 (hide)

Owner Alcon, Inc.

Inventors Bingaman, David P.; Landers, Robert A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004308911

PCT Pub. Number WO2005/063249

Priority 60/531,811 22.12.03 US

Filing date 17 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 26 August 2010

International Classifications

A61K 31/26 (2006.01)

A61K 31/12 (2006.01) - Ketones

A61K 31/27 (2006.01)

A61K 31/325 (2006.01) - Carbamic acids

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/353 (2006.01)

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/385 (2006.01) - having two or more sulfur atoms in the same ring

A61K 31/497 (2006.01)

A61K 31/7048 (2006.01)

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/063249 Priority application(s): WO2005/063249

26 August 2010 Application Accepted

  Published as AU-B-2004308911

23 December 2010 Standard Patent Sealed

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308913-Florfenicol prodrug having improved water solubility

2004308908-HEH4 molecules and uses thereof